Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
OR4A44P (Olfactory receptor family 4 subfamily A member 44 pseudogene) is a human genomic locus classified as a pseudogene, meaning it does not encode a functional protein due to disruptive mutations such as premature stop codons or frameshifts[1][2][7]. It belongs to the olfactory receptor gene family, which typically encodes G protein-coupled receptors (GPCRs) responsible for odorant detection and signal transduction in the nose[1]. However, as a pseudogene, OR4A44P does not perform biological functions typical of active olfactory receptors and is not considered a therapeutic target. Pseudogenes in the olfactory receptor family arise from evolutionary loss of function; current data does not indicate disease relevance, drug interactions, or biomarker potential for OR4A44P[1][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Olfactory receptor family 4 subfamily A member 44 pseudogene (OR4A44P).